Radoslav Mladenov

660 total citations
23 papers, 547 citations indexed

About

Radoslav Mladenov is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Radoslav Mladenov has authored 23 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Molecular Biology. Recurrent topics in Radoslav Mladenov's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Toxin Mechanisms and Immunotoxins (9 papers) and Immunotherapy and Immune Responses (6 papers). Radoslav Mladenov is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Toxin Mechanisms and Immunotoxins (9 papers) and Immunotherapy and Immune Responses (6 papers). Radoslav Mladenov collaborates with scholars based in Germany, South Africa and Netherlands. Radoslav Mladenov's co-authors include Stefan Barth, Dmitrij Hristodorov, Rainer Fischer, Theo Thepen, Michael Hühn, Philip Engel, Antje C. Spieß, Gernot Jäger, Marion B. Ansorge‐Schumacher and Andre Jakoblinnert and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Communications and Green Chemistry.

In The Last Decade

Radoslav Mladenov

22 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Radoslav Mladenov Germany 13 275 190 148 101 90 23 547
Danfeng Luo China 17 328 1.2× 106 0.6× 159 1.1× 53 0.5× 160 1.8× 31 659
Giulia Pellizzari United Kingdom 8 253 0.9× 143 0.8× 111 0.8× 72 0.7× 160 1.8× 12 570
Halina Onishko United States 8 363 1.3× 170 0.9× 83 0.6× 65 0.6× 139 1.5× 10 601
Ze Tao China 11 166 0.6× 75 0.4× 123 0.8× 76 0.8× 75 0.8× 37 378
Dylan Ferreira Portugal 15 318 1.2× 154 0.8× 62 0.4× 54 0.5× 114 1.3× 24 486
Mark Prytyskach United States 9 207 0.8× 113 0.6× 169 1.1× 51 0.5× 95 1.1× 9 450
Dianlong Jia China 12 180 0.7× 57 0.3× 104 0.7× 77 0.8× 79 0.9× 27 357
Ai‐Hong Ma United States 13 397 1.4× 152 0.8× 132 0.9× 25 0.2× 245 2.7× 19 766
James R. Kintzing United States 7 481 1.7× 55 0.3× 66 0.4× 131 1.3× 86 1.0× 10 639
James W. Opzoomer United Kingdom 8 329 1.2× 275 1.4× 171 1.2× 53 0.5× 370 4.1× 11 828

Countries citing papers authored by Radoslav Mladenov

Since Specialization
Citations

This map shows the geographic impact of Radoslav Mladenov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radoslav Mladenov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radoslav Mladenov more than expected).

Fields of papers citing papers by Radoslav Mladenov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radoslav Mladenov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radoslav Mladenov. The network helps show where Radoslav Mladenov may publish in the future.

Co-authorship network of co-authors of Radoslav Mladenov

This figure shows the co-authorship network connecting the top 25 collaborators of Radoslav Mladenov. A scholar is included among the top collaborators of Radoslav Mladenov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radoslav Mladenov. Radoslav Mladenov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wawrzyniak, Marcin, Yasser Morsy, Radoslav Mladenov, et al.. (2021). Fucosylation and Sialylation of Fc-Fragment of anti-Tumour Necrosis Factor Alpha Antibodies do not Influence Their Immunogenicity in Monocyte-Derived Dendritic Cells. Journal of Crohn s and Colitis. 15(9). 1596–1601. 3 indexed citations
2.
Mladenov, Radoslav, Judith Niesen, Tim H. Brümmendorf, et al.. (2017). Elimination of different leukaemia subtypes using novel CD89‐specific human cytolytic fusion proteins. British Journal of Haematology. 183(2). 313–317. 7 indexed citations
3.
Hristodorov, Dmitrij, et al.. (2017). Human MAP Tau Based Targeted Cytolytic Fusion Proteins. Biomedicines. 5(3). 36–36. 12 indexed citations
4.
Mladenov, Radoslav, Elmar G. Weinhold, Rainer Fischer, et al.. (2017). Fine Tuning Antibody Conjugation Methods using SNAP-tag Technology. Anti-Cancer Agents in Medicinal Chemistry. 17(10). 1434–1440. 3 indexed citations
5.
Mladenov, Radoslav, Anh‐Tuan Pham, Dmitrij Hristodorov, et al.. (2016). A novel approach for targeted elimination of CSPG4‐positive triple‐negative breast cancer cells using a MAP tau‐based fusion protein. International Journal of Cancer. 139(4). 916–927. 29 indexed citations
6.
Pham, Anh‐Tuan, Dmitrij Hristodorov, Radoslav Mladenov, et al.. (2016). Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model. Cancer Letters. 372(2). 201–209. 36 indexed citations
7.
Hristodorov, Dmitrij, Radoslav Mladenov, Rainer Fischer, Stefan Barth, & Theo Thepen. (2016). Fully human MAP‐fusion protein selectively targets and eliminates proliferating CD64+M1 macrophages. Immunology and Cell Biology. 94(5). 470–478. 14 indexed citations
8.
Mladenov, Radoslav, Dmitrij Hristodorov, Diana Klose, et al.. (2016). CD64-directed microtubule associated protein tau kills leukemic blastsex vivo. Oncotarget. 7(41). 67166–67174. 11 indexed citations
9.
Hristodorov, Dmitrij, Radoslav Mladenov, Verena von Felbert, et al.. (2015). Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies. mAbs. 7(5). 853–862. 59 indexed citations
10.
Mladenov, Radoslav, Xiaojing Cong, Edgar Jost, et al.. (2015). Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivo. Cancer Immunology Immunotherapy. 64(12). 1575–1586. 11 indexed citations
11.
Hristodorov, Dmitrij, Radoslav Mladenov, Judith Niesen, et al.. (2015). Targeted killing of rhabdomyosarcoma cells by a MAP-based human cytolytic fusion protein. Cancer Letters. 365(2). 149–155. 10 indexed citations
12.
Mladenov, Radoslav, Dmitrij Hristodorov, Judith Niesen, et al.. (2015). The Fc‐alpha receptor is a new target antigen for immunotherapy of myeloid leukemia. International Journal of Cancer. 137(11). 2729–2738. 15 indexed citations
13.
Hristodorov, Dmitrij, Radoslav Mladenov, Judith Niesen, et al.. (2014). EpCAM-Selective Elimination of Carcinoma Cells by a Novel MAP-Based Cytolytic Fusion Protein. Molecular Cancer Therapeutics. 13(9). 2194–2202. 18 indexed citations
14.
Niesen, Judith, Radoslav Mladenov, Christoph Stein, et al.. (2014). A CSPG4-specific immunotoxin kills rhabdomyosarcoma cells and binds to primary tumor tissues. Cancer Letters. 352(2). 228–235. 21 indexed citations
15.
Hristodorov, Dmitrij, et al.. (2014). Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. mAbs. 6(5). 1283–1289. 7 indexed citations
16.
Schiffer, Sonja, Edgar Jost, Radoslav Mladenov, et al.. (2013). Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells. Cancer Letters. 341(2). 178–185. 23 indexed citations
17.
Schiffer, Sonja, Dmitrij Hristodorov, Radoslav Mladenov, et al.. (2013). Species-Dependent Functionality of the Human Cytolytic Fusion Proteins Granzyme B-H22(scFv) and H22(scFv)-Angiogenin in Macrophages. SHILAP Revista de lepidopterología. 2(1). 9–18. 10 indexed citations
18.
Hristodorov, Dmitrij, et al.. (2013). Fighting chronic inflammation - CD64-specific elimination of M1 macrophages. Frontiers in Immunology. 4.
19.
Jakoblinnert, Andre, Radoslav Mladenov, Fabrizio Sibilla, et al.. (2011). Asymmetric reduction of ketones with recombinant E. coli whole cells in neat substrates. Chemical Communications. 47(44). 12230–12230. 96 indexed citations
20.
Engel, Philip, et al.. (2010). Point by point analysis: how ionic liquid affects the enzymatic hydrolysis of native and modified cellulose. Green Chemistry. 12(11). 1959–1959. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danfeng Luo Breakdown of academic impact, for papers by Giulia Pellizzari Breakdown of academic impact, for papers by Halina Onishko Breakdown of academic impact, for papers by Ze Tao Breakdown of academic impact, for papers by Dylan Ferreira Breakdown of academic impact, for papers by Mark Prytyskach Breakdown of academic impact, for papers by Dianlong Jia Breakdown of academic impact, for papers by Ai‐Hong Ma Breakdown of academic impact, for papers by James R. Kintzing Breakdown of academic impact, for papers by James W. Opzoomer
Rankless by CCL
2026